Boston Scientific (BSX)

R&D Expense Growth

7.36%

Quarterly · Period ending:

BSX logo

BSX R&D Expense Growth

Latest reported7.36%
BSX Quarterly R&D Growth (QoQ) (0.00% → 7.36%)
High-resolution chart · PNG

BSX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
7.3643%
-9.3146%
10.7004%
-2.2814%
18.7359%
-3.6957%
13.0221%
6.2663%
4.6448%
0.8264%
1.9663%
-0.8357%
6.5282%
2.1212%
-2.6549%
1.194%
5.0157%
-0.3125%
3.2258%
4.0268%
7.971%
-3.4965%
-9.2063%
30.1653%
-19.3333%
-2.9126%
0.9804%
9.2857%
0%
-2.7778%
-0.346%
5.0909%
5.364%
-1.1364%
3.937%
4.0984%
3.8298%
-8.2031%
10.3448%
4.5045%
5.7143%
-13.9344%
10.4072%
0.4545%
14.5833%
-7.6923%
-1.8868%
2.9126%
7.8534%
-11.5741%
-0.4608%
-2.6906%
9.3137%
-14.6444%
8.6364%
3.2864%
-0.9302%
-6.5217%
0.4367%
2.6906%
5.1887%
-5.7778%
-2.1739%
-0.8621%
-8.3004%
4.9793%
-6.5891%
-1.9011%
2.3346%
0%
1.9841%
-0.3953%
3.6885%
-4.6875%
-5.5351%
-1.4545%
-6.4626%
10.1124%
-1.8382%
-3.8869%
52.1505%
6.8966%
-3.8674%
9.0361%
4.4025%
0.6329%
8.9655%
9.8485%
-1.4925%
4.6875%
13.2743%
4.6296%
4.8544%
8.4211%
9.1954%
2.3529%
11.8421%
137.8109%
-345.122%
15.493%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.